NASDAQ:ARQT

Arcutis Biotherapeutics Stock Forecast

etoro logo Buy ARQT
*Your capital is at risk
$27.67
+1.60 (+6.14%)
At Close: Jul 07, 2026
AI Analysis AI Analysis of ARQT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ARQT to Watchlist?
Some Reasons Why To Add ARQT:
  • +101.1% price growth over the last year
  • High gross margin of 90.9%
  • Low bankruptcy risk (Altman Z-Score: 5.37)
PDF

A very strong day for Arcutis Biotherapeutics Inc stock price on Tuesday
(Updated on Jul 07, 2026)

Buy or Hold candidate since Jun 09, 2026 Gain 21.41%

The Arcutis Biotherapeutics Inc stock price gained 6.14% on the last trading day (Tuesday, 7th Jul 2026), rising from $26.07 to $27.67. During the last trading day the stock fluctuated 6.51% from a day low at $26.10 to a day high of $27.80. The price has fallen in 6 of the last 10 days but is still up by 3.79% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $66.32 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $27.70 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 10.08% during the next 3 months and, with a 90% probability hold a price between $22.93 and $30.50 at the end of this 3-month period.

ARQT Signals & Forecast

The Arcutis Biotherapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $26.48 and $23.65. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 41.90%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Arcutis Biotherapeutics Inc stock

Arcutis Biotherapeutics Inc finds support from accumulated volume at $27.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.70 between high and low, or 6.51%. For the last week, the stock has had daily average volatility of 4.02%.

Our recommended stop-loss: $26.65 (-3.68%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 32 days ago.)

Trading Expectations (ARQT) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Arcutis Biotherapeutics Inc to open at $27.19, and during the day (based on 14 day Average True Range), to move between $27.11 and $28.23, which gives a possible trading interval of +/-$1.12 (+/-4.12%) up or down from last closing price. If Arcutis Biotherapeutics Inc takes out the full calculated possible swing range there will be an estimated 4.12% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $27.00, some $0.670 (2.42%) from the current price of $27.67, our system finds the risk reward attractive.

Is Arcutis Biotherapeutics Inc stock A Buy?

Arcutis Biotherapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 6.138 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $27.19 ( 1.74%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ARQT Performance

Trading levels for ARQT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 28.89 4.40%
R2 28.24 2.06%
R1 27.84 0.607%
Price 27.67
S1 26.54 -4.08%
S2 26.14 -5.53%
S3 25.49 -7.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 27.67
S1 27.00 -2.42%
S2 26.21 -5.28%
S3 21.69 -21.61%

FAQ

What is the symbol for Arcutis Biotherapeutics Inc Stock and on which exchange is it traded?
The symbol for Arcutis Biotherapeutics Inc is ARQT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arcutis Biotherapeutics Inc Stock?
Arcutis Biotherapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

How to buy Arcutis Biotherapeutics Inc Stock?
Arcutis Biotherapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcutis Biotherapeutics Inc Stock.

What's the current price of Arcutis Biotherapeutics Inc Stock?
As of the end of day on the Jul 07, 2026, the price of an Arcutis Biotherapeutics Inc (ARQT) share was $27.67.

What is the 52-week high and low for Arcutis Biotherapeutics Inc Stock?
The 52-week high for Arcutis Biotherapeutics Inc Stock is $31.77 and the 52-week low is $13.06.

What is the market capitalization of Arcutis Biotherapeutics Inc Stock?
As of the Jul 07, 2026, the market capitalization of Arcutis Biotherapeutics Inc is 3.461B.

When is the next earnings date for Arcutis Biotherapeutics Inc?
The upcoming earnings date for Arcutis Biotherapeutics Inc is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ARCUTIS BIOTHERAPEUTICS INC
Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
16.27% Jun 29
OSIS
$218.29
0.197% Jun 26
NMRK
$15.02
4.19% Jun 24
X
XMAX
$8.34
4.56% Jun 24
TTEK
$28.04
10.31% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE